Integra LifeSciences to acquire Surgical Innovation Associates for up to $140M

Integra LifeSciences has entered a definitive agreement to acquire Surgical Innovation Associates (SIA), which manufactures DuraSorb absorbable mesh for plastic and reconstructive surgery. The deal is valued at up to $140 million, with $50 million at closing and up to $90 million in milestones.

“Integra LifeSciences warrants great respect among physicians, and shares SIA’s origins in plastic surgery.”businesswire.com

• 1 source
• businesswire.comSurgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciencesMedia, Investor RelationsDec 1, 2022

Summarized from public sources; check the original articles before acting on it.